Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Habib

Showing results (461-470 of 497) with videos related to

Pageof 50
Sort By:
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|February 18, 2025
The Crosstalk with CXCL10-Rich Tumor-Associated Mast Cells Fuels Pancreatic Cancer Progression and Immune EscapeHanlin Yin, Qiangda Chen, Shanshan Gao, et al.
Annals of Surgery|April 12, 2024
Defining the Minimal and Optimal Thresholds for Lymph Node Resection and Examination for Intraductal Papillary Mucinous Neoplasm Derived Pancreatic Cancer: A Multicenter Retrospective AnalysisJoseph R Habib, Ingmar F Rompen, Sarah R Kaslow, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|September 11, 2020
Minimal main pancreatic duct dilatation in small branch duct intraductal papillary mucinous neoplasms associated with high-grade dysplasia or invasive carcinomaNeda Amini, Neda Rezaee, Joseph R Habib, et al.
JCO Precision Oncology|November 20, 2024
Development of a Composite Score Based on Carbohydrate Antigen 19-9 Dynamics to Predict Survival in Carbohydrate Antigen 19-9-Producing Patients With Pancreatic Ductal Adenocarcinoma After Neoadjuvant TreatmentIngmar F Rompen, Elisabetta Sereni, Joseph R Habib, et al.
Journal of Gastroenterology and Hepatology|August 1, 2024
Outcomes in intraductal papillary mucinous neoplasm-derived pancreatic cancer differ from PanIN-derived pancreatic cancerJoseph R Habib, Ingmar F Rompen, Ammar A Javed, et al.
Pancreas|June 18, 2024
Clinical Relevance of Cancerization of Ducts in Resected Pancreatic Ductal AdenocarcinomaBenedict Kinny-Köster, Yembur Ahmad, Michael J Pflüger, et al.
Surgery|May 22, 2026
Postpancreatectomy liver injury: A relevant entity in the modern era of pancreatic cancer surgery with hepatic vessel resection. A monocentric retrospective cohort studyAlessio Marchetti, Camila H Salinas, Jonathan Garnier, et al.
Occupational and Environmental Medicine|February 22, 2020
Associations of sickness absence for pain in the low back, neck and shoulders with wider propensity to painDavid Coggon, Georgia Ntani, Karen Walker-Bone, et al.
Journal of the National Cancer Institute|July 19, 2024
An international multi-institutional validation of T1 sub-staging of intraductal papillary mucinous neoplasm-derived pancreatic cancerJoseph R Habib, Ingmar F Rompen, Brady A Campbell, et al.
Annals of Surgical Oncology|January 4, 2025
ASO Visual Abstract: Defining and Predicting Early Recurrence for Optimal Treatment Strategies in Intraductal Papillary Mucinous Neoplasm-Derived Pancreatic Cancer--An International Multicenter StudyJoseph R Habib, Ammar A Javed, Ingmar F Rompen, et al.
Pageof 50

Showing results (461-470 of 497) with videos related to

Sort By:
Pageof 50
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|February 18, 2025
The Crosstalk with CXCL10-Rich Tumor-Associated Mast Cells Fuels Pancreatic Cancer Progression and Immune EscapeHanlin Yin, Qiangda Chen, Shanshan Gao, et al.
Annals of Surgery|April 12, 2024
Defining the Minimal and Optimal Thresholds for Lymph Node Resection and Examination for Intraductal Papillary Mucinous Neoplasm Derived Pancreatic Cancer: A Multicenter Retrospective AnalysisJoseph R Habib, Ingmar F Rompen, Sarah R Kaslow, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|September 11, 2020
Minimal main pancreatic duct dilatation in small branch duct intraductal papillary mucinous neoplasms associated with high-grade dysplasia or invasive carcinomaNeda Amini, Neda Rezaee, Joseph R Habib, et al.
JCO Precision Oncology|November 20, 2024
Development of a Composite Score Based on Carbohydrate Antigen 19-9 Dynamics to Predict Survival in Carbohydrate Antigen 19-9-Producing Patients With Pancreatic Ductal Adenocarcinoma After Neoadjuvant TreatmentIngmar F Rompen, Elisabetta Sereni, Joseph R Habib, et al.
Journal of Gastroenterology and Hepatology|August 1, 2024
Outcomes in intraductal papillary mucinous neoplasm-derived pancreatic cancer differ from PanIN-derived pancreatic cancerJoseph R Habib, Ingmar F Rompen, Ammar A Javed, et al.
Pancreas|June 18, 2024
Clinical Relevance of Cancerization of Ducts in Resected Pancreatic Ductal AdenocarcinomaBenedict Kinny-Köster, Yembur Ahmad, Michael J Pflüger, et al.
Surgery|May 22, 2026
Postpancreatectomy liver injury: A relevant entity in the modern era of pancreatic cancer surgery with hepatic vessel resection. A monocentric retrospective cohort studyAlessio Marchetti, Camila H Salinas, Jonathan Garnier, et al.
Occupational and Environmental Medicine|February 22, 2020
Associations of sickness absence for pain in the low back, neck and shoulders with wider propensity to painDavid Coggon, Georgia Ntani, Karen Walker-Bone, et al.
Journal of the National Cancer Institute|July 19, 2024
An international multi-institutional validation of T1 sub-staging of intraductal papillary mucinous neoplasm-derived pancreatic cancerJoseph R Habib, Ingmar F Rompen, Brady A Campbell, et al.
Annals of Surgical Oncology|January 4, 2025
ASO Visual Abstract: Defining and Predicting Early Recurrence for Optimal Treatment Strategies in Intraductal Papillary Mucinous Neoplasm-Derived Pancreatic Cancer--An International Multicenter StudyJoseph R Habib, Ammar A Javed, Ingmar F Rompen, et al.
Pageof 50